Published: Monday, November 30th, 2015
Scottish first for life saving heart device
The Golden Jubilee has become the first hospital in Scotland to implant a life saving new technology in a patient suffering from heart failure.
The MultiPoint Pacing (MPP) device is a potentially groundbreaking piece of technology used for administering Cardiac Resynchronisation Therapy (CRT) in heart failure patients.
CRT is administered to patients who have significant functional impairment of the Left Ventricle (LV – the main chamber of the heart), where the heart is unable to pump blood efficiently and is out of time with the rest of the heartbeat.
Up until recently, CRT devices only allowed for one area of the left ventricle to be stimulated, or paced, but MultiPoint Pacing allows two locations to be paced at the same time.
Dr Roy Gardner, Consultant Cardiologist at the Golden Jubilee National Hospital, said: "Traditionally, CRT devices only allow for one area of the heart to be stimulated, or paced. While this can have huge benefits for the patient, improving symptoms of breathlessness, heart function, as well as longevity, unfortunately only 70% of people will respond to this treatment.
"However, the new MultiPoint Pacing device has the ability to keep more of the heart beating in sync, with the hope of improving the response rate to CRT for a larger number of patients."
A large scale study is now under way to determine the potential benefits of MultiPoint Pacing to all patients requiring CRT. The Golden Jubilee team has successfully implanted several such devices, in an attempt to demonstrate improved responses to the treatment, potentially reducing hospitalisations, improving symptoms of heart failure and providing a better quality of life for this group of patients. Going forward it is hoped that MultiPoint pacing can become standard treatment for any patient requiring CRT.
The first MultiPoint Pacing device was implanted in Bernard Cunningham, from Glasgow, who was originally treated for a severely impaired heart and dangerous heart rhythm, (arrhythmia) earlier this year, before being transferred to the Golden Jubilee.
The device was implanted in March 2015 stimulating the left ventricle to help the affected area keep in time with the rest of the heart.
Discussing the treatment, Mr Cunningham said: "I was originally taken into hospital when I had some chest pains; to be honest I originally thought it was indigestion and didn't think it was much to worry about. I quickly realised something was wrong and phoned an ambulance...it's just as well I did.
"I was transferred to the Golden Jubilee a couple of weeks later and discovered I was the first patient to be fitted with an MPP CRT device in Scotland. It's taken a bit of getting used to the device, but I feel great and I can't thank the team enough for everything they have done for me."
As the home of Innovation for the NHS in Scotland, the Golden Jubilee has a very strong track record of pioneering new treatments and research for the benefit of its patients.
Commenting on this latest development, Chief Executive of the Golden Jubilee Foundation, Jill Young, said: "We are delighted to be leading on this amazing development for NHSScotland, providing the highest possible standard of care for our patients and pride ourselves on having an ethos of continuous improvement with a vision of leading quality,research and innovation in healthcare.
"Developments like this are crucial, and going forward we will continue to find new, exciting and ways of providing safe, effective and person centred care for every patient that walks through our doors."